Fennec Pharmaceuticals is a commercial-stage oncology supportive-care company centered on Pedmark/Pedmarqsi. Read why FENC stock is a Buy.
Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals' Second Quarter 2025 Earnings and Corporate Update Conference Call. [Operator Instructions] As a reminder, today's conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback